First HAART in HIV-infected patients with high viral load

Value of HIV RNA levels at 12 weeks to predict virologic outcome

David L Townsend, Jesús Troya, Ivana Maida, Leticia Pérez-Saleme, Giovanni Satta, Aimee Wilkin, Pablo Barreiro, P. Samuel Pegram, Vincent Soriano, Maria Stella Mura, Marina Núñez

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The aim of this study is to identify the role of incomplete suppression during the first months of highly active antiretroviral treatment (HAART) to predict virologic failure in patients with high levels of HIV replication. In a retrospective, longitudinal, and multicenter study, response to HAART was assessed in treatment-naive adults with HIV RNA >100 000 copies/mL, and factors predicting failure were analyzed through regression analyses. A total of 118 patients were included. Virologic failure occurred more often in patients with >500 copies/mL at week 12 (Cox regression: Exp (B) 3.22; P =.02). HIV RNA >500 copies/mL at week 12 predicted incomplete virologic response (odds ratio [OR] = 9.33; P =.002] but not viral rebound. Major antiretroviral resistant mutations were present in 11 of 14 patients. HIV RNA >500 copies/mL at week 12 of first HAART predicts incomplete virologic response in patients with high levels of replication at baseline. Most patients carried resistance mutations at the time of failure.

Original languageEnglish (US)
Pages (from-to)314-317
Number of pages4
JournalJournal of the International Association of Physicians in AIDS Care
Volume8
Issue number5
DOIs
StatePublished - Sep 1 2009
Externally publishedYes

Fingerprint

Viral Load
HIV
RNA
Therapeutics
Mutation
Multicenter Studies
Longitudinal Studies
Retrospective Studies
Odds Ratio
Regression Analysis

Keywords

  • HAART
  • HIV
  • high viral load
  • resistance mutations
  • virologic failure

ASJC Scopus subject areas

  • Immunology
  • Dermatology
  • Infectious Diseases

Cite this

First HAART in HIV-infected patients with high viral load : Value of HIV RNA levels at 12 weeks to predict virologic outcome. / Townsend, David L; Troya, Jesús; Maida, Ivana; Pérez-Saleme, Leticia; Satta, Giovanni; Wilkin, Aimee; Barreiro, Pablo; Pegram, P. Samuel; Soriano, Vincent; Mura, Maria Stella; Núñez, Marina.

In: Journal of the International Association of Physicians in AIDS Care, Vol. 8, No. 5, 01.09.2009, p. 314-317.

Research output: Contribution to journalArticle

Townsend, David L ; Troya, Jesús ; Maida, Ivana ; Pérez-Saleme, Leticia ; Satta, Giovanni ; Wilkin, Aimee ; Barreiro, Pablo ; Pegram, P. Samuel ; Soriano, Vincent ; Mura, Maria Stella ; Núñez, Marina. / First HAART in HIV-infected patients with high viral load : Value of HIV RNA levels at 12 weeks to predict virologic outcome. In: Journal of the International Association of Physicians in AIDS Care. 2009 ; Vol. 8, No. 5. pp. 314-317.
@article{5fe61b7a7d6442779e7fa89efc587ae5,
title = "First HAART in HIV-infected patients with high viral load: Value of HIV RNA levels at 12 weeks to predict virologic outcome",
abstract = "The aim of this study is to identify the role of incomplete suppression during the first months of highly active antiretroviral treatment (HAART) to predict virologic failure in patients with high levels of HIV replication. In a retrospective, longitudinal, and multicenter study, response to HAART was assessed in treatment-naive adults with HIV RNA >100 000 copies/mL, and factors predicting failure were analyzed through regression analyses. A total of 118 patients were included. Virologic failure occurred more often in patients with >500 copies/mL at week 12 (Cox regression: Exp (B) 3.22; P =.02). HIV RNA >500 copies/mL at week 12 predicted incomplete virologic response (odds ratio [OR] = 9.33; P =.002] but not viral rebound. Major antiretroviral resistant mutations were present in 11 of 14 patients. HIV RNA >500 copies/mL at week 12 of first HAART predicts incomplete virologic response in patients with high levels of replication at baseline. Most patients carried resistance mutations at the time of failure.",
keywords = "HAART, HIV, high viral load, resistance mutations, virologic failure",
author = "Townsend, {David L} and Jes{\'u}s Troya and Ivana Maida and Leticia P{\'e}rez-Saleme and Giovanni Satta and Aimee Wilkin and Pablo Barreiro and Pegram, {P. Samuel} and Vincent Soriano and Mura, {Maria Stella} and Marina N{\'u}{\~n}ez",
year = "2009",
month = "9",
day = "1",
doi = "10.1177/1545109709343966",
language = "English (US)",
volume = "8",
pages = "314--317",
journal = "Journal of the International Association of Physicians in AIDS Care",
issn = "1545-1097",
publisher = "SAGE Publications Inc.",
number = "5",

}

TY - JOUR

T1 - First HAART in HIV-infected patients with high viral load

T2 - Value of HIV RNA levels at 12 weeks to predict virologic outcome

AU - Townsend, David L

AU - Troya, Jesús

AU - Maida, Ivana

AU - Pérez-Saleme, Leticia

AU - Satta, Giovanni

AU - Wilkin, Aimee

AU - Barreiro, Pablo

AU - Pegram, P. Samuel

AU - Soriano, Vincent

AU - Mura, Maria Stella

AU - Núñez, Marina

PY - 2009/9/1

Y1 - 2009/9/1

N2 - The aim of this study is to identify the role of incomplete suppression during the first months of highly active antiretroviral treatment (HAART) to predict virologic failure in patients with high levels of HIV replication. In a retrospective, longitudinal, and multicenter study, response to HAART was assessed in treatment-naive adults with HIV RNA >100 000 copies/mL, and factors predicting failure were analyzed through regression analyses. A total of 118 patients were included. Virologic failure occurred more often in patients with >500 copies/mL at week 12 (Cox regression: Exp (B) 3.22; P =.02). HIV RNA >500 copies/mL at week 12 predicted incomplete virologic response (odds ratio [OR] = 9.33; P =.002] but not viral rebound. Major antiretroviral resistant mutations were present in 11 of 14 patients. HIV RNA >500 copies/mL at week 12 of first HAART predicts incomplete virologic response in patients with high levels of replication at baseline. Most patients carried resistance mutations at the time of failure.

AB - The aim of this study is to identify the role of incomplete suppression during the first months of highly active antiretroviral treatment (HAART) to predict virologic failure in patients with high levels of HIV replication. In a retrospective, longitudinal, and multicenter study, response to HAART was assessed in treatment-naive adults with HIV RNA >100 000 copies/mL, and factors predicting failure were analyzed through regression analyses. A total of 118 patients were included. Virologic failure occurred more often in patients with >500 copies/mL at week 12 (Cox regression: Exp (B) 3.22; P =.02). HIV RNA >500 copies/mL at week 12 predicted incomplete virologic response (odds ratio [OR] = 9.33; P =.002] but not viral rebound. Major antiretroviral resistant mutations were present in 11 of 14 patients. HIV RNA >500 copies/mL at week 12 of first HAART predicts incomplete virologic response in patients with high levels of replication at baseline. Most patients carried resistance mutations at the time of failure.

KW - HAART

KW - HIV

KW - high viral load

KW - resistance mutations

KW - virologic failure

UR - http://www.scopus.com/inward/record.url?scp=75349106109&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75349106109&partnerID=8YFLogxK

U2 - 10.1177/1545109709343966

DO - 10.1177/1545109709343966

M3 - Article

VL - 8

SP - 314

EP - 317

JO - Journal of the International Association of Physicians in AIDS Care

JF - Journal of the International Association of Physicians in AIDS Care

SN - 1545-1097

IS - 5

ER -